| E2F1 drives breast cancer metastasis by regulating the target gene FGF13 and altering cell migration DP Hollern, MR Swiatnicki, JP Rennhack, SA Misek, BC Matson, ... Scientific reports 9 (1), 10718, 2019 | 71 | 2019 |
| Histological subtypes of mouse mammary tumors reveal conserved relationships to human cancers DP Hollern, MR Swiatnicki, ER Andrechek PLoS genetics 14 (1), e1007135, 2018 | 67 | 2018 |
| Integrated analyses of murine breast cancer models reveal critical parallels with human disease JP Rennhack, B To, M Swiatnicki, C Dulak, MP Ogrodzinski, Y Zhang, C Li, ... Nature communications 10 (1), 3261, 2019 | 53 | 2019 |
| Reduction of global H3K27me3 enhances HER2/ErbB2 targeted therapy A Hirukawa, S Singh, J Wang, JP Rennhack, M Swiatnicki, ... Cell Reports 29 (2), 249-257. e8, 2019 | 38 | 2019 |
| An ErbB2/c-Src axis links bioenergetics with PRC2 translation to drive epigenetic reprogramming and mammary tumorigenesis HW Smith, A Hirukawa, V Sanguin-Gendreau, I Nandi, CR Dufour, D Zuo, ... Nature Communications 10 (1), 2901, 2019 | 29 | 2019 |
| Elevated phosphorylation of EGFR in NSCLC due to mutations in PTPRH MR Swiatnicki, JP Rennhack, MMO Ortiz, DP Hollern, AV Perry, R Kubiak, ... PLoS Genetics 18 (9), e1010362, 2022 | 7 | 2022 |
| How to choose a mouse model of breast cancer, a genomic perspective MR Swiatnicki, ER Andrechek Journal of mammary gland biology and neoplasia 24, 231-243, 2019 | 7 | 2019 |
| Protomer selectivity of type II RAF inhibitors within the RAS/RAF complex JD Vasta, A Michaud, CA Zimprich, MT Beck, MR Swiatnicki, H Zegzouti, ... Cell Chemical Biology 30 (11), 1354-1365. e6, 2023 | 6 | 2023 |
| Metastasis is altered through multiple processes regulated by the E2F1 transcription factor MR Swiatnicki, ER Andrechek Scientific Reports 11 (1), 9502, 2021 | 3 | 2021 |
| Profiling oncogenic KRAS mutant drugs with a cell-based Lumit p-ERK immunoassay M Swiatnicki, L Engel, R Shrestha, J Alves, SA Goueli, H Zegzouti SLAS Discovery 27 (4), 249-257, 2022 | 2 | 2022 |
| A25 PTPRH Mutations in NSCLC Regulate EGFR Phosphorylation MR Swiatnicki, JP Rennhack, ER Andrechek Journal of Thoracic Oncology 15 (2), S20, 2020 | 2 | 2020 |
| Integrated sequence and gene expression analysis of mouse models of breast cancer reveals critical events with human parallels JP Rennhack, M Swiatnicki, Y Zhang, C Li, E Bylett, C Ross, ... bioRxiv, 375154, 2018 | 2 | 2018 |
| Lumit immunoassay: a versatile bioluminescent approach for probing cellular signaling pathway regulation through protein phosphorylation and degradation H Zegzouti, M Swiatnicki, L Engel, J Alves, S Goueli, J Cali Journal of Biological Chemistry 299 (3), S804, 2023 | | 2023 |
| Profiling Oncogenic Ras Mutant Drugs with Homogeneous Bioluminescent Immunoassays. H Zegzouti, L Engel, M Swiatnicki, J Alves, S Goueli FASEB Journal: Official Publication of the Federation of American Societies …, 2022 | | 2022 |
| Genetically Engineered Mouse Models Predict Actionable Mutations in Human Cancers MR Swiatnicki Michigan State University, 2021 | | 2021 |
